Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
277.00    -12.00 (-4.15%)
Bid:
275.00
Ask:
279.00
Spread: 4.00 (1.455%)
Market Cap: £248.99m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Trading update

16 Oct 2025 07:00

RNS Number : 5726D
Norcros PLC
16 October 2025
 

16 October 2025

 

 

Trading update

 

Norcros plc ("Norcros" or the "Group"), the number one bathroom products business in the UK and Ireland, will announce its Interim Results for the 27 weeks to 5 October 2025 on 20 November 2025. In advance of this, the Group provides the following trading update.

 

Strategic delivery and market share gains drive margin progression

 

The Group has delivered a robust first-half performance, underpinned by the strength of our market leading brands in a demand environment that remains challenging.

 

Strategic delivery continues with the closure of Johnson Tiles SA, the ongoing implementation of our operational excellence initiatives, and the acquisition of Fibo Holding AS in Norway shortly after the end of the period. In addition, our exciting new product development programme, combined with ongoing cross-selling continue to drive profitable organic market share growth and margin improvement. We are well positioned to further accelerate growth in both the RMI and Housebuilding markets when market conditions improve.

 

After a slow start to the period, like-for-like (LFL1) revenue on a constant currency (CC2) basis was 3% ahead of the prior year in both regions in the last 18 weeks. Group revenue for the 27-week period is expected to be 1% ahead of the prior year on a LFL CC basis. Reported3 revenue is expected to be approximately £184 million (20243: £181.9 million), reflecting the increase to a 27 week period versus 26 week period in the prior year, offset by the exit of Johnson Tiles UK in the prior year.

 

 

 

H1 LFL1 revenue

9 weeks ending 1 June 2025

18 weeks ending 5 October 2025

FY26 H1

UK & Ireland

-3%

3%

1%

South Africa

-7%

0%

-2%

South Africa at CC4

-4%

3%

1%

Group

-5%

2%

0%

Group at CC

-4%

3%

1%

 

 

Group underlying continuing operating profit4 is expected to be c.£21.8 million (20243: £20.4 million) in the first half of the year. Group operating margins in the period have increased to c.11.9% (2024: 11.2%) with our core UK&I market operating margin up to c.14.8% (2024: 13.6%).

 

 

Financial position

 

The Group remains in a strong financial position with closing5 net debt (on a pre-IFRS 16 basis) expected to be c. £31 million (net debt of £44.9 million as at 30 September 2024 and £36.8 million as at 31 March 2025). This represents leverage of approximately 0.6x underlying EBITDA, providing a solid foundation for further strategic delivery.

 

Acquisition of Fibo Holding AS

 

On 15 July 2025, the Group announced the proposed acquisition of Fibo Holding AS ("Fibo"), a leading supplier of high-quality waterproof decorative wall panels. Post the period end and as communicated on 13 October 2025, the CMA review process has approved the acquisition which has now completed5. We are delighted to welcome our new colleagues at Fibo to the Norcros group.

 

Outlook

 

The Board remains confident that our market leading positions and implementation of our strategy will continue to deliver market share gains for the year ending 31 March 2026. Despite the ongoing challenging market conditions, the Board expects full year underlying operating profit to be in line with market6 expectations, and to show further progress towards our medium-term strategic targets.

 

 

1. LFL (like for like) adjusted from a 27 to 26 week period pro-rating and Johnson Tiles UK which was sold in the prior year

2. CC refers to constant currency basis 

3. Discontinued Johnson Tiles SA is not included in either the current or prior year figures

4. Underlying operating profit is defined as operating profit from continuing operations before non-underlying and exceptional operating items

5.  At the period end of 5 October 2025 net debt of c.£31m represents leverage of c.0.6x. Post the period end and the acquisition of Fibo, proforma leverage is expected to be c.1.6x

6. Norcros compiled consensus for FY26 underlying operating profit previously was £43.9m to £45.2m excluding Fibo and is currently £47.2m to £48.7m including Fibo

 

 

 

 

Enquiries

Norcros plc

Tel: 01625 547700

Thomas Willcocks, Chief Executive Officer

James Eyre, Chief Financial Officer

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

Josh Hayler

 

 

 

About Norcros

Norcros is a market leading group of brands specialising in design led, sustainable bathroom products across the UK, Ireland, Scandinavia, South Africa, and select export markets. Each of our brands offers mid-premium product ranges distinguished by their innovation, design, and commitment to sustainability, all backed by industry leading service to our trade and retail customers.

 

Through a strategic blend of acquisitions and organic growth, Norcros has become the UK and Ireland's number one bathroom products group. We see significant potential for further expansion within this large and fragmented market, accelerating growth and capturing market share through continued acquisitions, organic development, operational excellence, and meaningful ESG capabilities.

 

Norcros encompasses the renowned brands: Triton, Merlyn, Grant Westfield, Vado, Croydex, and Abode in the UK and Ireland, Fibo in Norway and Tile Africa, TAL, and House of Plumbing in South Africa.

 

Norcros is headquartered in Wilmslow, Cheshire and employs around 2,100 people. The Company is listed on the London Stock Exchange. For further information please visit the Company website: www.norcros.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTLELLFEBLXFBE
Date   Source Headline
21st May 20267:00 amRNS-RInvestor Presentation Webinar on 18 June 2026
12th May 20267:00 amRNSStrategic update: South African operations
30th Apr 202611:42 amRNSTotal Voting Rights
16th Apr 20267:00 amRNSYear-end Trading and Board update
2nd Apr 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSBlock Listing Six Monthly Return
3rd Mar 20269:29 amRNSDirectors Share Dealing - correction
3rd Mar 20267:00 amRNSDirectors Share Dealing
2nd Feb 20267:00 amRNSAppointment of Joint Corporate Broker
14th Jan 202612:12 pmRNSDirectors Share Dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
28th Nov 20254:03 pmRNSHolding(s) in Company
20th Nov 20256:22 pmRNSDirectors Share Dealing
20th Nov 20257:00 amRNSInterim Results
12th Nov 20257:00 amRNS-RInvestor Presentation Webinar on 1 December 2025
21st Oct 20255:04 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSTrading update
13th Oct 20257:24 amRNSCompletion of Acquisition of Fibo Holding AS
30th Sep 202511:46 amRNSBlock Listing Six Monthly Return
23rd Jul 202512:03 pmRNSDirector Dealings - APSP and DBP Share Options
23rd Jul 202511:59 amRNSResults of AGM
23rd Jul 20257:11 amRNSAGM Trading Statement
21st Jul 20254:11 pmRNSDirector Dealings - DBP Share Option exercises
16th Jul 20255:01 pmRNSTotal Voting Rights
15th Jul 20257:00 amRNSAcquisition of Fibo Holding AS
23rd Jun 20257:00 amRNSJTSA Outcome of Strategic Review
20th Jun 20254:10 pmRNSAnnual Financial Report and Notice of 2025 AGM
12th Jun 20257:00 amRNSResults for the year ended 31 March 2025
3rd Jun 20257:00 amRNS-RInvestor Webinar
10th Apr 20257:00 amRNSTrading update for the year ended 31 March 2025
31st Mar 20257:00 amRNSBlock Listing 6 Monthly Return
31st Mar 20257:00 amRNSTotal Voting Rights
13th Mar 20257:00 amRNSPension Scheme Valuation Update
5th Feb 20253:45 pmRNSDirectors Share Dealing
31st Dec 20247:00 amRNSVoting Rights and Share Capital Update
10th Dec 202411:49 amRNSHolding(s) in Company
6th Dec 202411:52 amRNSHolding(s) in Company
3rd Dec 20244:39 pmRNSTotal Voting Rights
21st Nov 20245:01 pmRNSHolding(s) in Company
21st Nov 202411:57 amRNSInterim Results - Replacement
21st Nov 20247:00 amRNSResults for the six months ended 30 September 2024
1st Nov 20247:00 amRNSTotal Voting Rights
10th Oct 20247:00 amRNSTrading update
1st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 202410:08 amRNSBlock listing Six Monthly Return
30th Aug 20247:00 amRNSTotal Voting Rights
24th Jul 20241:50 pmRNSResults of AGM
24th Jul 20241:24 pmRNSDirector Dealings - APSP Share Option Awards
24th Jul 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.